Spike stimulation increases IL-2 levels in patients with hematological malignancies, but the IFN-γ and tumor necrosis factor α (TNF-α) remain lower, which indicates a reduced magnitude of protection by T cell response [68]. This evidence concerns the gene IL2 and hematologic disorder.